Please be advised that you are now leaving the Werfen website. Links are provided as a convenience and for informational purposes only. Werfen bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.
Event
Optimizing Heparin Management Strategies to Improve Patient Outcomes
This symposium will focus on the use of heparin management strategies to optimize patient outcomes via multiple testing techniques. Implementation of Anti-Xa testing for heparin monitoring and heparin-related complications will be covered.
Following the workshop, Werfen representatives will be available online to answer questions.
Date
This event took place on October 24, 2023 and is now available on-demand.
Times
To accommodate time zones around the world, this program is offered at multiple times, in English. When registering, please select the time that best accommodates your schedule.
11:00 AM–2:00 PM ET
7:00 PM–10:00 PM ET
Objectives
- Define the benefits of Anti-Xa testing for heparin monitoring.
- Highlight the health-economic benefits of Anti-Xa versus aPTT testing for heparin monitoring.
- Discuss the diagnosis and management of heparin-induced thrombocytopenia, with case examples.
Speakers
Deepa Jayakody Arachchillage, MD, MBBS, MRCP, FRCPath
Imperial College London; Hammersmith Hospital, London, England
K. Maria Notini, MT (ASCP)
Duke University Medical Center, Durham, NC, US
Ted E. Warkentin, MD, BSc(Med), FRCP(C), FACP
McMaster University; Hamilton General Hospital, Hamilton, ON, Canada
Annie Winkler, MD
Werfen, Bedford, MA, US
EVENTS
Upcoming Events
